Paper36034833
Bipartite graph search optimization for type II diabetes mellitus Jamu formulation using branch and bound algorithm.
Kusuma WA and 6 others. Front Pharmacol, 2022. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Bipartite graph search optimization for type II diabetes mellitus Jamu formulation using branch and bound algorithm. Papers, record 36034833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36034833
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bipartite graph search optimization for type II diabetes mellitus Jamu formulation using branch and bound algorithm.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33879050 | AutoDTI++: deep unsupervised learning for DTI prediction by autoencoders. | BMC Bioinformatics | 2021 | https://conductscience.org/library/papers/33879050 | PubMed |
| 2 | 33151290 | PubChem in 2021: new data content and improved web interfaces. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33151290 | PubMed |
| 3 | 23593264 | Drug target prediction and repositioning using an integrated network-based approach. | PLoS One | 2013 | https://conductscience.org/library/papers/23593264 | PubMed |
| 4 | 31199797 | DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/31199797 | PubMed |
| 5 | 30846939 | Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/30846939 | PubMed |
| 6 | 28334136 | A review of network-based approaches to drug repositioning. | Brief Bioinform | 2018 | https://conductscience.org/library/papers/28334136 | PubMed |
| 7 | 31689203 | Predicting Drug-Target Interactions With Multi-Label Classification and Label Partitioning. | IEEE/ACM Trans Comput Biol Bioinform | 2021 | https://conductscience.org/library/papers/31689203 | PubMed |
| 8 | 18586719 | Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. | Bioinformatics | 2008 | https://conductscience.org/library/papers/18586719 | PubMed |
| 9 | 15688074 | Multicomponent therapeutics for networked systems. | Nat Rev Drug Discov | 2005 | https://conductscience.org/library/papers/15688074 | PubMed |
| 10 | 22749929 | Network-based characterization of drug-regulated genes, drug targets, and toxicity. | Methods | 2012 | https://conductscience.org/library/papers/22749929 | PubMed |
| 11 | 27167301 | Computational Protein Design Using AND/OR Branch-and-Bound Search. | J Comput Biol | 2016 | https://conductscience.org/library/papers/27167301 | PubMed |
| 12 | 23106776 | Efficacy prediction of jamu formulations by PLS modeling. | Curr Comput Aided Drug Des | 2013 | https://conductscience.org/library/papers/23106776 | PubMed |
| 13 | 35631398 | Network Pharmacology Approach for Medicinal Plants: Review and Assessment. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35631398 | PubMed |
| 14 | 35922786 | Virtual screening of Indonesian herbal compounds as COVID-19 supportive therapy: machine learning and pharmacophore modeling approaches. | BMC Complement Med Ther | 2022 | https://conductscience.org/library/papers/35922786 | PubMed |
| 15 | 21576229 | ChemMine tools: an online service for analyzing and clustering small molecules. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21576229 | PubMed |
| 16 | 19337271 | A network view of disease and compound screening. | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19337271 | PubMed |
| 17 | 27899599 | PubChem BioAssay: 2017 update. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/27899599 | PubMed |
| 18 | 18936753 | Network pharmacology: the next paradigm in drug discovery. | Nat Chem Biol | 2008 | https://conductscience.org/library/papers/18936753 | PubMed |
| 19 | 23737854 | A network pharmacology approach to evaluating the efficacy of chinese medicine using genome-wide transcriptional expression data. | Evid Based Complement Alternat Med | 2013 | https://conductscience.org/library/papers/23737854 | PubMed |
| 20 | 18229694 | Mining metabolic networks for optimal drug targets. | Pac Symp Biocomput | 2008 | https://conductscience.org/library/papers/18229694 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PTPN1 | 5770 | PubTator's text mining | https://conductscience.org/library/genes/5770 | NCBI Gene |
| TCF7L2 | 6934 | PubTator's text mining | https://conductscience.org/library/genes/6934 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36034833
GET https://conductscience.org/api/papers/v1/36034833/references?page=2